On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells

被引：21

作者：

Ntolkeras, Georgios ^{[1
]}

Barba, Chrysanthi ^{[1
]}

Mavropoulos, Athanasios ^{[1
]}

Vasileiadis, Georgios K. ^{[1
]}

Dardiotis, Efthymios ^{[2
]}

Sakkas, Lazaros I. ^{[1
]}

Hadjigeorgiou, Georgios ^{[2
,3
]}

Bogdanos, Dimitrios P. ^{[1
]}

机构：

[1] Univ Thessaly, Univ Gen Hosp Larissa, Sch Hlth Sci, Dept Rheumatol & Clin Immunol,Fac Med, Biopolis 40500, Larissa, Greece

[2] Univ Thessaly, Univ Gen Hosp Larissa, Sch Hlth Sci, Dept Neurol & Lab Neurogenet,Fac Med, Viopolis 40500, Larissa, Greece

[3] Univ Cyprus, Sch Med, Dept Neurol, Nicosia, Cyprus

来源：

IMMUNOLOGIC RESEARCH | 2019年 / 67卷 / 4-5期

关键词：

Autoimmunity; Demyelination; Inflammation; Regulation; Statin; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COA REDUCTASE INHIBITORS; MODIFIED DENDRITIC CELLS; HIGH-DOSE SIMVASTATIN; IMMUNOMODULATORY SYNERGY; MONOCLONAL-ANTIBODIES; ANTIGEN PRESENTATION; GLATIRAMER ACETATE; ENDOTHELIAL-CELLS;

D O I：

10.1007/s12026-019-09089-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Statins, the cholesterol-lowering drugs, also possess immunomodulatory properties, affecting among others T cell activation and differentiation, antigen presentation, and regulatory T cell (Tregs) maintenance and differentiation. Their effects on autoagression have led investigators to assess their clinical significance in autoimmune disease, such as multiple sclerosis (MS), a chronic progressive demyelinating disease of autoimmune nature. The dysregulated immunity noted in MS features a profound shift from Tregs dominance to Th17 cell superiority. In this review, we discuss the immunobiological basis of statins, their role in autoimmunity related to MS, and the data from experimental models and human studies on their effect on Th17 cells.

引用

页码：310 / 324

页数：15

共 50 条

[1] On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells
Georgios Ntolkeras
Chrysanthi Barba
Athanasios Mavropoulos
Georgios K. Vasileiadis
Efthymios Dardiotis
Lazaros I. Sakkas
Georgios Hadjigeorgiou
Dimitrios P. Bogdanos
Immunologic Research, 2019, 67 : 310 - 324
[2] Effects of Catecholamines on Th17 Cells in Multiple Sclerosis
Mel’nikov M.V.
Belousova O.O.
Zhetishev R.R.
Pashchenkov M.V.
Boiko A.N.
Neuroscience and Behavioral Physiology, 2018, 48 (3) : 342 - 345
[3] The role of TH17 cells in multiple sclerosis: Therapeutic implications
Moser, Tobias
Akgun, Katja
Proschmann, Undine
Sellner, Johann
Ziemssen, Tjalf
AUTOIMMUNITY REVIEWS, 2020, 19 (10)
[4] Th17 cells in the pathogenesis of multiple sclerosis
Juszczak, Marek
Glabinski, Andrzej
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2009, 63 : 492 - 501
[5] Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells
Pennell, Leesa M.
Fish, Eleanor N.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (05): : 330 - 341
[6] Relevance of human Th17 cells in multiple sclerosis
Brucklacher-Waldert, Verena
Stuerner, Klarissa
Wolthausen, Julia
Heesen, Christoph
Martin, Roland
Tolosa, Eva
JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 163 - 163
[7] Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
McGinley, Aoife M.
Edwards, Sarah C.
Raverdeau, Mathilde
Mills, Kingston H. G.
JOURNAL OF AUTOIMMUNITY, 2018, 87 : 97 - 108
[8] Th17 cells in pathogenesis of experimental model of multiple sclerosis
Wojkowska, Dagmara
Glabinski, Andrzej
AKTUALNOSCI NEUROLOGICZNE, 2011, 11 (02): : 100 - 105
[9] CCR6+Th1 and Th17 Cells in Multiple Sclerosis
Kalra, Seema
Curnow, John S.
Hawkins, Clive P.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 103 - 103
[10] Characterization of Th17 cells in multiple sclerosis patients and healthy controls
Buehler, Ulrike
Gollan, Rene
Belikan, Patrick
Zipp, Frauke
Siffrin, Volker
JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 140 - 141

← 1 2 3 4 5 →